Spark Therapeutics Inc Asset Turnover Ratio (ONCE), as of third quarter 2019, current and historic results, rankings and more - CSIMarket
CSIMarket
 


Spark Therapeutics Inc   (NASDAQ: ONCE)
 

Spark Therapeutics Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Spark Therapeutics Inc asset turnover ratio, the ability of Spark Therapeutics Inc 's assets to generate revenue in the third quarter 2019, increased sequentially to 0.09 in the third quarter (Sep 30 2019), a new company high.

Within sector 40 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the III Quarter 2019, to 3531, from total ranking in the second quarter 2019 at 3707.

Asset Turnover Ratio Definition



ONCE Asset Turnover Ratio (Sep 30 2019)
III. Quarter
(Jun 30 2019)
II. Quarter
(Mar 31 2019)
I. Quarter
(Dec 31 2018)
IV. Quarter
(Sep 30 2018)
III. Quarter
Y / Y Asset Change -12.87 % -3.01 % 9.86 % 32.03 % 31.78 %
Y / Y Revenue Change 109.65 % -46.38 % 32.5 % 77.6 % 463.65 %
Asset Turnover Ratio (TTM) 0.09 0.07 0.09 0.08 0.08
ONCE's Total Ranking # 3531 # 3707 # 3707 # 2066 # 3707
Seq. Asset Change -6.23 % -0.7 % -7.23 % 0.86 % 4.38 %
Seq. Revenue Change 66.24 % -34.99 % 57.87 % 22.88 % -57.49 %



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 41
Healthcare Sector # 482
Overall Market # 3531

Asset Turnover Ratio Statistics
High Average Low
0.09 0.07 0.03
(Sep 30 2019)   (Dec 31 2017)







Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2019, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2019 Assets at quarter ending Sep 30 2019
Prestige Consumer Healthcare Inc   0.27 $ 952.663  Millions$ 3,508.647  Millions
Checkpoint Therapeutics inc   0.27 $ 4.714  Millions$ 17.373  Millions
Bausch Health Companies Inc   0.26 $ 8,498.000  Millions$ 32,266.000  Millions
Axim Biotechnologies Inc   0.26 $ 0.680  Millions$ 2.591  Millions
Gw Pharmaceuticals Plc  0.26 $ 208.910  Millions$ 799.063  Millions
Travere Therapeutics Inc   0.26 $ 172.421  Millions$ 659.555  Millions
Palvella Therapeutics Inc   0.26 $ 33.922  Millions$ 129.995  Millions
Xoma Royalty Corporation  0.26 $ 19.633  Millions$ 75.987  Millions
China Pharma Holdings Inc  0.26 $ 11.118  Millions$ 43.387  Millions
American Cryostem Corporation  0.25 $ 0.322  Millions$ 1.265  Millions
Reshape Lifesciences Inc  0.25 $ 11.489  Millions$ 45.392  Millions
Repligen Corp  0.25 $ 252.713  Millions$ 1,004.879  Millions
Xencor Inc  0.25 $ 164.748  Millions$ 661.183  Millions
Adamas Pharmaceuticals Inc  0.25 $ 51.604  Millions$ 209.677  Millions
Cti Biopharma Corp   0.25 $ 17.822  Millions$ 72.606  Millions
Guardant Health Inc   0.24 $ 184.351  Millions$ 763.724  Millions
Stemline Therapeutics Inc  0.24 $ 31.588  Millions$ 131.494  Millions
Protalix Biotherapeutics inc   0.24 $ 13.842  Millions$ 57.787  Millions
Portola Pharmaceuticals inc   0.24 $ 102.690  Millions$ 432.621  Millions
Denali Therapeutics Inc   0.23 $ 147.682  Millions$ 644.791  Millions
Novan Inc   0.23 $ 7.553  Millions$ 33.095  Millions
Lifeward ltd   0.23 $ 5.271  Millions$ 23.099  Millions
Flexion Therapeutics Inc   0.23 $ 58.846  Millions$ 259.301  Millions
Igc Pharma Inc   0.23 $ 6.297  Millions$ 27.928  Millions
Delcath Systems Inc   0.22 $ 2.085  Millions$ 9.385  Millions
Guided Therapeutics Inc   0.22 $ 0.063  Millions$ 0.284  Millions
Progyny Inc   0.22 $ 61.196  Millions$ 281.009  Millions
Arvinas Inc   0.22 $ 41.523  Millions$ 191.747  Millions
Skinvisible Inc   0.21 $ 0.045  Millions$ 0.211  Millions
Assertio Holdings inc   0.21 $ 180.739  Millions$ 846.518  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.